Abstract #4028
13C MRS shows that mutant IDH1 glioma cells alter flux through pyruvate dehydrogenase and pyruvate carboxylase
Larry M Cai 1 , Jose L Izquierdo-Garcia 1 , Myriam M Chaumeil 1 , Pia Eriksson 1 , Joanna J Phillips 2 , Russell O Pieper 2 , and Sabrina M Ronen 1
1
Radiology, UCSF, San Francisco, CA, United
States,
2
Neurological
Surgery, UCSF, San Francisco, CA, United States
The IDH1 mutation (IDHmut) is associated with low-grade
gliomas. By taking advantage of glutamate labeling
patterns from 2-13C-glucose, we show, using 13C MRS of
two glioma cell lines, that IDHmut cells decrease flux
through pyruvate dehydrogenase (PDH) compared to
pyruvate carboxylase (PC). In both cell lines, this is
accompanied by a decrease in PDH expression and
activity, an increase in PC expression and activity, and
an increase in PDH inhibitory phosphorylation. Taken
together, these results reveal potential sites of
metabolic reprogramming in IDHmut gliomas.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
